Key facts
- It has raised $14.1M; the latest was Early Stage VC ($14.1M) in Nov 2025.
- Notable investors include Qiming Venture Partners, Lotus Lake Ventures, ChuangVest Ventures.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Ronghe Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Ronghe Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Ronghe Medical
Manufacturer of respiratory interventional medical devices intended for clinical treatment purposes. The company offers design, research and development, production, and operation with features such as multi-level device categories, intellectual property including patents and trademarks, and specialized technology services covering consultation, transfer, and promotion, enabling healthcare institutions to access reliable solutions that support precision treatment, operational efficiency, and compliance with regulatory standards.
- Sector
- Healthcare
- HQ
- Jiaxing, China
- Founded
- 2022
- Ownership
- Privately Held (backing)
Ronghe Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Ronghe Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Ronghe Medical in its N-PORT filings yet. We sweep new filings monthly.